Skip to main content
AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
4.330
-0.230 (-5.04%)
At close: Apr 28, 2026, 4:00 PM EDT
4.410
+0.080 (1.85%)
After-hours: Apr 28, 2026, 5:57 PM EDT

AVITA Medical Revenue

In the year 2025, AVITA Medical had annual revenue of $71.61M with 11.45% growth. AVITA Medical had revenue of $17.62M in the quarter ending December 31, 2025, a decrease of -4.30%.

Revenue (ttm)
$71.61M
Revenue Growth
+11.45%
P/S Ratio
1.86
Revenue / Employee
$316,858
Employees
226
Market Cap
133.26M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202571.61M7.36M11.45%
Dec 31, 202464.25M14.11M28.14%
Dec 31, 202350.14M15.72M45.68%
Dec 31, 202234.42M1.40M4.23%
Dec 31, 202133.03M3.79M12.98%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 348.67M
Treace Medical Concepts 212.69M
Neuronetics 149.16M
Quanterix 138.90M
Owlet 105.71M
Apyx Medical 52.84M
SANUWAVE Health 44.05M
Rapid Micro Biosystems 33.59M
Revenue Rankings

RCEL News

More News